A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Pfizer
Tempus AI
Elevation Oncology
PureTech
Carisma Therapeutics Inc
Celldex Therapeutics
Klus Pharma Inc.
Xencor, Inc.
MacroGenics
SpeciCare
INSYS Therapeutics Inc